Nicholas Elias Houstis, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise Tolerance | 7 | 2020 | 836 | 1.190 |
Why?
|
Stroke Volume | 8 | 2020 | 5497 | 0.670 |
Why?
|
Exercise Test | 8 | 2022 | 2129 | 0.640 |
Why?
|
Oxygen Consumption | 4 | 2021 | 1863 | 0.590 |
Why?
|
Heart Failure | 11 | 2021 | 11674 | 0.500 |
Why?
|
Ventricular Function, Left | 4 | 2020 | 3879 | 0.450 |
Why?
|
Exercise | 9 | 2024 | 5884 | 0.360 |
Why?
|
Boidae | 1 | 2022 | 14 | 0.210 |
Why?
|
Dyspnea | 2 | 2020 | 1347 | 0.200 |
Why?
|
Shock | 1 | 2023 | 314 | 0.180 |
Why?
|
Heart Rate | 3 | 2021 | 4198 | 0.170 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2023 | 481 | 0.170 |
Why?
|
Proteomics | 2 | 2024 | 3845 | 0.160 |
Why?
|
Physical Conditioning, Animal | 1 | 2022 | 365 | 0.160 |
Why?
|
Activin Receptors, Type II | 1 | 2019 | 123 | 0.150 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2022 | 241 | 0.150 |
Why?
|
Pulmonary Ventilation | 1 | 2020 | 372 | 0.150 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2141 | 0.150 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2019 | 273 | 0.150 |
Why?
|
Muscle, Skeletal | 4 | 2019 | 4946 | 0.140 |
Why?
|
Health Status | 2 | 2021 | 4075 | 0.130 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 898 | 0.130 |
Why?
|
Myocardium | 2 | 2019 | 4725 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 782 | 0.120 |
Why?
|
Blood Proteins | 1 | 2020 | 1180 | 0.120 |
Why?
|
Hemodynamics | 2 | 2023 | 4168 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 987 | 0.110 |
Why?
|
Insulin Resistance | 2 | 2007 | 3963 | 0.110 |
Why?
|
Aging | 3 | 2020 | 8705 | 0.100 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15498 | 0.090 |
Why?
|
Metabolomics | 1 | 2020 | 1657 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1897 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2023 | 3744 | 0.090 |
Why?
|
Motor Activity | 1 | 2019 | 2711 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1580 | 0.080 |
Why?
|
Physical Fitness | 2 | 2022 | 739 | 0.070 |
Why?
|
Systole | 2 | 2020 | 937 | 0.070 |
Why?
|
Reference Values | 1 | 2014 | 4921 | 0.070 |
Why?
|
Metalloporphyrins | 1 | 2006 | 41 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 250 | 0.070 |
Why?
|
Body Mass Index | 2 | 2021 | 12951 | 0.070 |
Why?
|
Male | 19 | 2024 | 360736 | 0.060 |
Why?
|
3T3-L1 Cells | 1 | 2006 | 209 | 0.060 |
Why?
|
Catalase | 1 | 2006 | 218 | 0.060 |
Why?
|
Glucose Tolerance Test | 2 | 2006 | 1179 | 0.060 |
Why?
|
Middle Aged | 13 | 2024 | 220826 | 0.060 |
Why?
|
Mice, Obese | 1 | 2006 | 420 | 0.060 |
Why?
|
Humans | 24 | 2024 | 761423 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15262 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4405 | 0.060 |
Why?
|
Macrophages | 2 | 2018 | 5768 | 0.060 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 594 | 0.050 |
Why?
|
Oncogene Proteins | 1 | 2007 | 718 | 0.050 |
Why?
|
Thiazolidinediones | 1 | 2006 | 461 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10498 | 0.050 |
Why?
|
Transgenes | 1 | 2006 | 1010 | 0.050 |
Why?
|
Aged | 9 | 2024 | 169235 | 0.050 |
Why?
|
Female | 14 | 2024 | 392581 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9995 | 0.050 |
Why?
|
Oxygen | 2 | 2023 | 4228 | 0.050 |
Why?
|
Oxidative Phosphorylation | 1 | 2003 | 496 | 0.050 |
Why?
|
Rodentia | 1 | 2022 | 262 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29620 | 0.040 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 2230 | 0.040 |
Why?
|
Follistatin-Related Proteins | 1 | 2019 | 48 | 0.040 |
Why?
|
Animals | 10 | 2022 | 168441 | 0.040 |
Why?
|
Signal Transduction | 2 | 2019 | 23441 | 0.040 |
Why?
|
Obesity | 4 | 2023 | 12938 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1373 | 0.040 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 128 | 0.040 |
Why?
|
Risk Factors | 3 | 2024 | 74167 | 0.040 |
Why?
|
Autocrine Communication | 1 | 2019 | 169 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1669 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 22163 | 0.040 |
Why?
|
PPAR alpha | 1 | 2019 | 175 | 0.040 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2019 | 269 | 0.040 |
Why?
|
Activins | 1 | 2019 | 210 | 0.040 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2019 | 411 | 0.040 |
Why?
|
Mice | 6 | 2020 | 81509 | 0.030 |
Why?
|
Blood Pressure | 2 | 2023 | 8487 | 0.030 |
Why?
|
Physical Exertion | 1 | 2019 | 667 | 0.030 |
Why?
|
Adult | 8 | 2024 | 221148 | 0.030 |
Why?
|
Models, Animal | 1 | 2022 | 2113 | 0.030 |
Why?
|
Pressure | 1 | 2019 | 1155 | 0.030 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2019 | 542 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1097 | 0.030 |
Why?
|
Body Weight | 1 | 2006 | 4618 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1808 | 0.030 |
Why?
|
Pulmonary Gas Exchange | 1 | 2014 | 379 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1320 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1175 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2020 | 2116 | 0.020 |
Why?
|
Ligands | 1 | 2019 | 3271 | 0.020 |
Why?
|
Prospective Studies | 3 | 2021 | 54415 | 0.020 |
Why?
|
Glucose | 2 | 2019 | 4347 | 0.020 |
Why?
|
Fatty Acids | 1 | 2019 | 1808 | 0.020 |
Why?
|
Genetic Loci | 1 | 2020 | 2631 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5246 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2455 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2019 | 1668 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41446 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 80582 | 0.020 |
Why?
|
Insulin | 2 | 2019 | 6602 | 0.020 |
Why?
|
Monocytes | 1 | 2018 | 2572 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2018 | 2049 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7392 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9612 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8320 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 4991 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8832 | 0.020 |
Why?
|
Cardiovascular System | 1 | 2015 | 835 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4140 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2019 | 3816 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3321 | 0.020 |
Why?
|
Lipocalins | 1 | 2007 | 161 | 0.020 |
Why?
|
3T3 Cells | 1 | 2007 | 1085 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14599 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2007 | 1762 | 0.010 |
Why?
|
Young Adult | 2 | 2022 | 59207 | 0.010 |
Why?
|
Transcription Factors | 1 | 2003 | 12125 | 0.010 |
Why?
|
Rats | 1 | 2019 | 23742 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14409 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16606 | 0.010 |
Why?
|
Myoblasts | 1 | 2003 | 231 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 64651 | 0.010 |
Why?
|
Stromal Cells | 1 | 2007 | 1330 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15838 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12688 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6395 | 0.010 |
Why?
|
Adipocytes | 1 | 2007 | 1194 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18247 | 0.010 |
Why?
|
Transfection | 1 | 2007 | 5775 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2003 | 12143 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 39975 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39117 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6086 | 0.010 |
Why?
|
Hypertension | 1 | 2018 | 8542 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6532 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3340 | 0.010 |
Why?
|
Down-Regulation | 1 | 2003 | 2918 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2007 | 3312 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3779 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58956 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2007 | 11526 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11902 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2003 | 12796 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2003 | 18964 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9418 | 0.000 |
Why?
|